| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,426 |
5,381 |
$4.78M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,550 |
7,950 |
$4.45M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
65,084 |
53,496 |
$3.60M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,761 |
7,633 |
$2.62M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,270 |
23,672 |
$2.08M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,509 |
11,751 |
$510K |
| 80053 |
Comprehensive metabolic panel |
13,947 |
11,440 |
$339K |
| 36415 |
Collection of venous blood by venipuncture |
18,229 |
14,925 |
$326K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,077 |
8,989 |
$278K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,301 |
3,669 |
$182K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,764 |
1,380 |
$175K |
| 84484 |
|
1,646 |
819 |
$99K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,748 |
2,342 |
$67K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
453 |
269 |
$51K |
| 87631 |
|
361 |
317 |
$50K |
| 81001 |
|
2,990 |
2,485 |
$45K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
633 |
513 |
$42K |
| 80061 |
Lipid panel |
1,190 |
1,065 |
$42K |
| 71045 |
Radiologic examination, chest; single view |
724 |
548 |
$39K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
356 |
325 |
$32K |
| 99215 |
Prolong outpt/office vis |
260 |
225 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
286 |
119 |
$29K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,718 |
1,573 |
$29K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
311 |
242 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
676 |
613 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
389 |
357 |
$21K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
268 |
200 |
$19K |
| 83605 |
|
403 |
286 |
$16K |
| 83735 |
|
533 |
426 |
$15K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
17 |
12 |
$14K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
114 |
57 |
$10K |
| 83690 |
|
571 |
452 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
565 |
508 |
$10K |
| 90686 |
|
784 |
709 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
53 |
37 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
213 |
206 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
68 |
56 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
65 |
52 |
$6K |
| 80305 |
|
287 |
103 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
26 |
24 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
449 |
385 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
52 |
49 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
261 |
234 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
182 |
163 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
21 |
13 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
43 |
41 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
166 |
136 |
$3K |
| 97602 |
|
126 |
41 |
$3K |
| 85610 |
|
427 |
297 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
59 |
51 |
$3K |
| 85730 |
|
104 |
80 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
63 |
54 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
75 |
24 |
$3K |
| 97597 |
|
63 |
25 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
29 |
13 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
43 |
40 |
$2K |
| 84100 |
|
113 |
92 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
43 |
40 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
213 |
163 |
$2K |
| 84703 |
|
26 |
25 |
$2K |
| 84460 |
|
103 |
85 |
$2K |
| 84450 |
|
103 |
85 |
$2K |
| 73630 |
|
55 |
37 |
$2K |
| 83880 |
|
17 |
13 |
$1K |
| 11102 |
|
24 |
12 |
$1K |
| 82728 |
|
44 |
38 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15 |
15 |
$1K |
| 84439 |
|
37 |
36 |
$1K |
| 82607 |
|
32 |
27 |
$920.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
44 |
43 |
$800.21 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
30 |
24 |
$594.62 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13 |
12 |
$583.92 |
| 84481 |
|
25 |
24 |
$576.66 |
| 20610 |
|
27 |
12 |
$506.21 |
| 82746 |
|
17 |
13 |
$488.40 |
| 85027 |
|
26 |
26 |
$476.87 |
| 0064A |
|
32 |
28 |
$448.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
53 |
50 |
$403.39 |
| 83540 |
|
13 |
12 |
$396.76 |
| 90656 |
|
15 |
14 |
$343.91 |
| 83550 |
|
13 |
12 |
$278.41 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15 |
13 |
$258.50 |
| 81025 |
|
12 |
12 |
$174.81 |
| 81002 |
|
33 |
24 |
$170.56 |
| 90662 |
|
22 |
19 |
$87.59 |
| G0008 |
Administration of influenza virus vaccine |
87 |
58 |
$85.52 |
| 84145 |
|
16 |
13 |
$0.00 |